The Relationship of Tumor-infiltrating Lymphocyte Ratio with Histopathological Parameters and Effect on Survival in Colorectal Cancers
Introduction: Tumor lymphocyte infiltration demonstrates a positive effect on patient survival in breast cancer, melanoma, renal cell carcinoma, and lung cancer.This study aimed to elucidate the relationship between tumor-infiltrating lymphocyte (TIL) ratio and disease-free survival (DFS) and overall survival (OS) by considering localization, clinical and pathological features, microsatellite instability (MSI) status, mutation status, and demographic data.Method: Patients (n=248) diagnosed with colorectal cancer stages 1, 2, and 3 were analyzed retrospectively.Patients with an Eastern Cooperative Oncology Group performance score of <2 were excluded.Clinical characteristics, age, gender, histopathologic features, TIL ratio, and carcinoembryonic antigen (CEA) level of the patients were recorded.Results: Stage, CEA level, TIL ratio, N stage, T stage, and lymphovascular invasion were statistically significant.Early stage (p=0.019),low CEA level (p0.001),high TIL ratio (p=0.046),low N stage (p=0.004),low T stage (p=0.016),and absence of lymphovascular invasion (p=0.037 and p=0.046) were associated with longer DFS.Lymphovascular invasion, N stage, CEA levels, and TIL ratio were analyzed using multivariate analysis.According to the results, the hazard ratio (HR) for the TIL ratio was 1.68 (95% confidence interval (CI): 1.005-2.807;p=0.048), and the HR for the CEA level was 0.49 (95% CI: 0.293-0.846;p=0.01). Conclusion:Regarding the outcomes of this research, the TIL ratio was found to be an effective indicator of DFS, confirmed via multivariate analysis to present a 32% reduction in the risk of recurrence/relapse.The TIL ratio was identified as a prognostic factor beyond the effects of stage, grade, lymphovascular invasion, CEA level, and MSI status.The current data provides substantial evidence to support the ratio's consideration in staging guidelines.
Authors
- İsra Serda Oğuz
- Özgecan Dülgar (ORCID: https://orcid.org/0000-0002-0678-4024)
- Mahmut Gümüş (ORCID: https://orcid.org/0009-0001-7894-2319)
- Sinan Koca (ORCID: https://orcid.org/0000-0002-2263-005X)
- Süleyman Ersoy (ORCID: https://orcid.org/0000-0003-0001-9329)
- Ayşenur Toksöz
Institutions
- Ümraniye Eğitim ve Araştırma Hastanesi (TR)
- Haydarpaşa Numune Eğitim ve Araştırma Hastanesi (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Istanbul Medeniyet University (TR)
Publication Details
- Journal
- Turkish Journal of Colorectal Disease
- Published
- 2024-12-30
- DOI
- https://doi.org/10.4274/tjcd.galenos.2024.2024-8-1
- Citations
- 2
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.57